Literature DB >> 1806055

Ultrastructural changes in the gracile nucleus of the spontaneously diabetic BB rat.

S S Tay1, W C Wong.   

Abstract

The present study describes the structural changes in the gracile nucleus of the spontaneously diabetic BB rat. At 3-7 days post-diabetes, axons, axon terminals and dendrites showed electron-dense degeneration. Degenerating axons were characterized by swollen mitochondria, vacuolation, accumulation of glycogen granules, tubulovesicular elements, neurofilaments and dense lamellar bodies. Degenerating axon terminals consisted of an electron-dense cytoplasm containing swollen mitochondria, vacuoles and clustering of synaptic vesicles. These axon terminals made synaptic contacts with cell somata, dendrites and other axon terminals. Degenerating dendrites were postsynaptic to normal as well as degenerating axon terminals. At 1-3 months post-diabetes, degenerating electron-dense axons, axon terminals and dendrites were widely scattered in the neuropil. Macrophages containing degenerating electron-dense debris were also present. At 6 months post-diabetes, the freshly degenerating neuronal elements encountered were similar to those observed at 3-7 days. However, there were more degenerating profiles at 6 months post-diabetes compared to the earlier time intervals. Terminally degenerating axons were vacuolated and their axoplasm appeared amorphous. It is concluded that degenerative changes occur in the gracile nucleus of the spontaneously diabetic BB rat.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1806055

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  2 in total

1.  Ultrastructural changes in the hypothalamic supraoptic nucleus of the streptozotocin-induced diabetic rat.

Authors:  S T Dheen; S S Tay; W C Wong
Journal:  J Anat       Date:  1994-06       Impact factor: 2.610

2.  Deleterious effects of neuronal accumulation of glycogen in flies and mice.

Authors:  Jordi Duran; María Florencia Tevy; Mar Garcia-Rocha; Joaquim Calbó; Marco Milán; Joan J Guinovart
Journal:  EMBO Mol Med       Date:  2012-05-02       Impact factor: 12.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.